Published by mark itwired
Posted on September 6, 2021
ESOMAR-certified consulting firm Future Market Insights’ (FMI’s) report forecasts the global industrial microbiology market to exhibit steady growth, surpassing a valuation of US$ 13,3072.73 Mn by 2021-end.
Growing application of industrial microbiology within pharmaceutical and food & beverage industry across China, the U.S., Germany and India will bolster the demand of industrial microbiology across the globe.
As per the FMI’s analysis, the industrial microbiology market across the U.S. and India is anticipated to expand at an impressive rate over the forecast period.
Growing adoption of sterility and bio-burden testing within pharmaceutical industry will foster the sales of industrial microbiology products.
Increasing research and development activities along with the increasing drug development within biopharmaceutical industry across the U.S., France, and India will bolster the market growth in the upcoming decade.
Increasing applications in pharmaceutical excipients have encouraged the adoption of sterility and bio-burden testing for the quality testing of drugs and micro-organisms. However, dearth of skilled labour and high-cost production is likely to hamper the growth of industrial microbiology.
Due to unprecedented outbreak of COVID-19, sales of industrial microbiology declined by 1.95%, exhibiting a CAGR at 4.95% during the forecast period.
However, with rising initiatives to reduce the pollution and improve the wastewater treatment efficiency, industrial microbiology market valuation will reach US$ 21,566.24 Mn by 2031.
Request Sample of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1743
“Key players are increasing research & development activities to facilitate drug discovery and food testing within the pharmaceutical & food industry. This, in turn, is likely to widen growth opportunities for the market players over the coming years,” says the FMI analyst.
Future Market Insights, in its updated report, have profiled prominent players operating in industrial microbiology market which include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Asiagel Corporation, Eppendorf AG, bioMérieux SA, Novamed., QIAGEN, Sartorius AG, 3M, Merck KGaA and Danaher Corporation among others.
Manufacturers of industrial microbiology systems are actively focusing on expanding their product portfolios to improve their revenue generation.
As per FMI, the market is dominated by top players such as Thermo Fisher Scientific Inc. and BioMerieuxx Inc. making the market consolidated.
Targeted mergers and collaborations with top healthcare and pharmaceutical companies is anticipated to be the key strategy to maintain their top position in the industry.
New product launches with the expansion of their existing product range is one of the common market strategy for the key players. For instance:
In March 2020, leading player, Danaher Corporation announced the acquisition of the biopharma business from the Life Sciences Division of General Electronics. With this acquisition, the company has been renamed as Cytiva and will be functioning as a standalone company within the Danaher Corporation.
Future Market Insights, in its latest report, offers an incisive coverage on the global industrial microbiology market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is classified on the basis of product type (equipment and systems, reaction consumables, and others), test type (sterility testing, microbial limits testing, and bio-burden testing), and end user (pharmaceutical & biotechnology, food & beverages, agriculture & environmental, and personal care products) across seven major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)
Any Queries, ask us @ https://www.futuremarketinsights.com/ask-question/rep-gb-1743
The industrial microbiology market is expected to surpass a valuation of approx. US$ 13,302.73 Mn in 2021.
The industrial microbiology market witnessed steady growth at 6.90% CAGR between 2016 and 2020.
Increasing application of empty capsules in pharmaceutical sector and adoption of wastewater treatment to improve the efficiency & reduce the pollution will foster the sales over the forecast period.
Thermo Fisher Scientific Inc, bioMérieux SA, and Merck KGaA. are the top three players leading the industrial microbiology market.
Sales in North America for industrial microbiology will account for over 27% of global market share in 2021.
Germany is expected to spearhead the market growth across Europe, contributing over 31% of global market share in anti-ageing products, services, and devices market.
The U.S., UK, Germany, China, and France are the top countries driving the industrial microbiology market.
The post The Global Industrial Microbiology Market Size Worth US$ 21.56 Billion By 2031 | FMI first appeared on Market Research Blog.
ESOMAR-certified consulting firm Future Market Insights’ (FMI’s) report forecasts the global industrial microbiology market to exhibit steady growth, surpassing a valuation of US$ 13,3072.73 Mn by 2021-end.
Growing application of industrial microbiology within pharmaceutical and food & beverage industry across China, the U.S., Germany and India will bolster the demand of industrial microbiology across the globe.
As per the FMI’s analysis, the industrial microbiology market across the U.S. and India is anticipated to expand at an impressive rate over the forecast period.
Growing adoption of sterility and bio-burden testing within pharmaceutical industry will foster the sales of industrial microbiology products.
Increasing research and development activities along with the increasing drug development within biopharmaceutical industry across the U.S., France, and India will bolster the market growth in the upcoming decade.
Increasing applications in pharmaceutical excipients have encouraged the adoption of sterility and bio-burden testing for the quality testing of drugs and micro-organisms. However, dearth of skilled labour and high-cost production is likely to hamper the growth of industrial microbiology.
Due to unprecedented outbreak of COVID-19, sales of industrial microbiology declined by 1.95%, exhibiting a CAGR at 4.95% during the forecast period.
However, with rising initiatives to reduce the pollution and improve the wastewater treatment efficiency, industrial microbiology market valuation will reach US$ 21,566.24 Mn by 2031.
Request Sample of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1743
“Key players are increasing research & development activities to facilitate drug discovery and food testing within the pharmaceutical & food industry. This, in turn, is likely to widen growth opportunities for the market players over the coming years,” says the FMI analyst.
Future Market Insights, in its updated report, have profiled prominent players operating in industrial microbiology market which include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Asiagel Corporation, Eppendorf AG, bioMérieux SA, Novamed., QIAGEN, Sartorius AG, 3M, Merck KGaA and Danaher Corporation among others.
Manufacturers of industrial microbiology systems are actively focusing on expanding their product portfolios to improve their revenue generation.
As per FMI, the market is dominated by top players such as Thermo Fisher Scientific Inc. and BioMerieuxx Inc. making the market consolidated.
Targeted mergers and collaborations with top healthcare and pharmaceutical companies is anticipated to be the key strategy to maintain their top position in the industry.
New product launches with the expansion of their existing product range is one of the common market strategy for the key players. For instance:
In March 2020, leading player, Danaher Corporation announced the acquisition of the biopharma business from the Life Sciences Division of General Electronics. With this acquisition, the company has been renamed as Cytiva and will be functioning as a standalone company within the Danaher Corporation.
Future Market Insights, in its latest report, offers an incisive coverage on the global industrial microbiology market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is classified on the basis of product type (equipment and systems, reaction consumables, and others), test type (sterility testing, microbial limits testing, and bio-burden testing), and end user (pharmaceutical & biotechnology, food & beverages, agriculture & environmental, and personal care products) across seven major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)
Any Queries, ask us @ https://www.futuremarketinsights.com/ask-question/rep-gb-1743
The industrial microbiology market is expected to surpass a valuation of approx. US$ 13,302.73 Mn in 2021.
The industrial microbiology market witnessed steady growth at 6.90% CAGR between 2016 and 2020.
Increasing application of empty capsules in pharmaceutical sector and adoption of wastewater treatment to improve the efficiency & reduce the pollution will foster the sales over the forecast period.
Thermo Fisher Scientific Inc, bioMérieux SA, and Merck KGaA. are the top three players leading the industrial microbiology market.
Sales in North America for industrial microbiology will account for over 27% of global market share in 2021.
Germany is expected to spearhead the market growth across Europe, contributing over 31% of global market share in anti-ageing products, services, and devices market.
The U.S., UK, Germany, China, and France are the top countries driving the industrial microbiology market.
The post The Global Industrial Microbiology Market Size Worth US$ 21.56 Billion By 2031 | FMI first appeared on Market Research Blog.
